Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

63.75
Delayed Data
As of Oct 23
 -0.67 / -1.04%
Today’s Change
46.01
Today|||52-Week Range
66.10
+9.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$105.6B

Company Description

Bristol-Myers Squibb Co. operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Contact Information

Bristol-Myers Squibb Co.
345 Park Avenue
New York New York 10154
P:(212) 546-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders38.55%
Other institutional32.73%
Individual stakeholders0.39%

Top Executives

Giovanni CaforioChairman & Chief Executive Officer
Charles A. BancroftCFO, EVP & Head-Global Business Operations
Paul von AutenriedChief Information Officer & Senior Vice President
Thomas James LynchChief Scientific Officer & Executive VP
Anne N. NielsenChief Compliance & Ethics Officer, Senior VP